FAFaisal Ameer

Faisal Ameer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Faisal Ameer has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Brian J Smith

    The Queen Elizabeth Hospital Department of Medicine, University of Adelaide Adelaide Australia

    1 shared publication
  • Kristin Carson-Chahhoud

    Adelaide Medical School; The University of Adelaide; Adelaide Australia

    1 shared publication
  • Zafar A Usmani

    The Queen Elizabeth Hospital Department of Respiratory Medicine 4A, Main Building, 28 Woodville Road Woodville South Adelaide Australia SA 5011

    1 shared publication

Latest Publications

  • Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest

    by Faisal Ameer, Kristin V Carson, Zafar A Usmani, Brian J Smith

    People with chronic obstructive pulmonary disease (COPD) often become transiently hypoxaemic (low oxygen levels in blood) on exercise, necessitating oxygen therapy to improve breathlessness and exercise capacity and to reduce disability. Ambulatory oxygen therapy refers to provision of oxygen therapy during exercise and activities of daily living. Ambulatory oxygen therapy is often used by patients on long-term oxygen therapy (LTOT) during exercise or by non-LTOT users with or without resting hypoxaemia when they show evidence of exercise de-saturation and demonstrate improvement in exercise capacity with supplemental oxygen. To determine the longer-term efficacy of ambulatory oxygen therapy only in patients with COPD who do not meet the criteria for LTOT, with respect to improvement in exercise capacity, mortality, quality of life and other relevant measures of improvement. The Cochrane Airways Group Specialised Register, including MEDLINE, EMBASE and CINAHL, was searched. Online clinical trial registers, including Controlled Clinical Trials (www.controlled-trials.com), government registries (clinicaltrials.gov) and World Health Organization (WHO) registries (www.who.int/trialsearch), were screened for ongoing and recently completed studies. Bibliographies of included studies were searched for additional trials that may meet the inclusion criteria and were not retrieved by the above search strategy. Authors of identified trials were contacted to provide other published and unpublished studies. Searches were current as of November 2012. Randomised controlled trials (RCTs) that compare ambulatory oxygen therapy provided through portable oxygen cylinders/battery-powered devices or liquid oxygen canisters versus placebo air cylinders, usual medical care or co-intervention in study participants with COPD who did not meet criteria for LTOT. We used standard methods as expected by The Cochrane Collaboration. Four studies met the inclusion criteria (331 participants), with two studies producing a statistically and clinically significant benefit in favour of the intervention for dyspnoea post exercise.The quality of life domain for all four included studies produced a statistically significant benefit for the subcategories of dyspnoea and fatigue, in favour of the oxygen group (dyspnoea mean difference (MD) 0.28, 95% confidence interval (CI) 0.10 to 0.45; P value 0.002; fatigue MD 0.17, 95% CI 0.04 to 0.31; P value 0.009). No evidence of any effect was reported for survival, and limited benefits were observed for exercise capacity (as measured by step test and distance walk test), with one study showing a statistically significant improvement in the number of steps taken in the oxygen group for group N-of-1 studies only. No other statistically significant benefits were observed for exercise capacity among the other trials or individual N-of-1 studies. In patients with COPD with moderate hypoxia, current evidence on ambulatory oxygen therapy reveals improvements in dyspnoea post exercise and in the dyspnoea and fatigue domain of quality of life. However, evidence for the clinical utility and effectiveness of ambulatory oxygen in improving mortality and exercise capacity was not evident in this review. Methodologically rigorous RCTs with sufficient power to detect a difference are required to investigate the role of ambulatory oxygen in the management of COPD. Oxygène ambulatoire pour les personnes atteintes de bronchopneumopathie chronique obstructive qui ne sont pas hypoxémiques au repos Les patients atteints de bronchopneumopathie chronique obstructive (BPCO) souffrent fréquemment d'hypoxémie transitoire (faible taux d'oxygène dans le sang) à l'exercice, nécessitant une oxygénothérapie afin d'améliorer l'essoufflement et la capacité d'exercice et réduire l'incapacité. L'oxygénothérapie ambulatoire fait référence à la fourniture d'oxygénothérapie pendant l'exercice et les activités de la vie quotidienne. L'oxygénothérapie ambulatoire est souvent utilisée par les patients sous oxygénothérapie de long terme (OTLD) pendant l'exercice ou par des usagers non-OTLD avec ou sans hypoxémie de repos lorsqu'ils montrent des signes de désaturation à l'effort et démontrent une amélioration de la capacité d'exercice avec de l'oxygène d'appoint. Déterminer l'efficacité à plus long terme de l'oxygénothérapie ambulatoire uniquement chez les patients atteints de BPCO qui ne remplissent pas les critères pour l'OTLD, en ce qui concerne l'amélioration de la capacité d'exercice, la mortalité, la qualité de vie et d'autres mesures pertinentes d'amélioration. Le registre spécialisé du groupe Cochrane sur les voies respiratoires, y compris MEDLINE, EMBASE et CINAHL, a été consulté. Des registres d'essais cliniques en ligne, y compris Controlled Clinical Trials (www.controlled-trials.com), des registres gouvernementaux (clinicaltrials.gov) et de l'Organisation mondiale de la Santé (OMS) (www.who.int/trialsearch), ont été examinés pour des études en cours ou récemment terminées. Les bibliographies des études incluses ont été consultées pour rechercher d'autres essais remplissant potentiellement les critères d'inclusion et qui n'auraient pas été retrouvés par la stratégie de recherche documentaire décrite ci-dessus. Les auteurs des essais identifiés ont été contactés afin d'obtenir d'autres études publiées et non publiées. Les recherches étaient à jour en novembre 2012. Essais contrôlés randomisés (ECR) comparant l'oxygénothérapie ambulatoire administrée par des bouteilles d'oxygène portatives, des dispositifs...